======= EFR3A ======= == Gene Information == * **Official Symbol**: EFR3A * **Official Name**: EFR3 homolog A * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23167|23167]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q14156|Q14156]] * **Interactions**: [[https://thebiogrid.org/search.php?search=EFR3A&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EFR3A|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611798|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is part of a complex that plays a role in maintaining an active pool of phosphatidylinositol 4-kinase (PI4K) at the plasma membrane. This protein is thought to be a peripheral membrane protein that associates with the plasma membrane through palmitoylation. Studies indicate that this gene product plays a role in controlling G protein-coupled receptor (GPCR) activity by affecting receptor phosphorylation. Whole exome sequencing studies have implicated mutations in this gene with autism spectrum disorders. [provided by RefSeq, Apr 2016]. * **UniProt Summary**: Component of a complex required to localize phosphatidylinositol 4-kinase (PI4K) to the plasma membrane (PubMed:23229899, PubMed:25608530, PubMed:26571211). The complex acts as a regulator of phosphatidylinositol 4-phosphate (PtdIns(4)P) synthesis (Probable). In the complex, EFR3A probably acts as the membrane-anchoring component (PubMed:23229899). Also involved in responsiveness to G-protein-coupled receptors; it is however unclear whether this role is direct or indirect (PubMed:25380825). {ECO:0000269|PubMed:23229899, ECO:0000269|PubMed:25380825, ECO:0000269|PubMed:25608530, ECO:0000305}. No Pfam Domain information is available for this gene. |phosphatidylinositol phosphorylation| |lipid phosphorylation| |phosphatidylinositol metabolic process| |protein localization to plasma membrane| |lipid modification| |protein localization to cell periphery| |glycerophospholipid metabolic process| |phospholipid metabolic process| |glycerolipid metabolic process| |protein localization to membrane| |organophosphate metabolic process| |cellular lipid metabolic process| |lipid metabolic process| |phosphorylation| |cellular protein localization| |cellular macromolecule localization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp134|MS023 2μM R03 exp134]]|-2.11| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|-1.83| |[[:results:exp149|SB203580 25μM R03 exp149]]|2.2| ^Gene^Correlation^ |[[:human genes:t:ttc7a|TTC7A]]|0.475| |[[:human genes:h:hars|HARS]]|0.415| Global Fraction of Cell Lines Where Essential: 44/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|3/28| |blood|0/28| |bone|0/26| |breast|1/33| |central nervous system|2/56| |cervix|0/4| |colorectal|2/17| |esophagus|0/13| |fibroblast|0/1| |gastric|1/16| |kidney|1/21| |liver|1/20| |lung|2/75| |lymphocyte|1/16| |ovary|4/26| |pancreas|4/24| |peripheral nervous system|0/16| |plasma cell|4/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|4/22| |urinary tract|2/29| |uterus|2/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1909 * **Expression level (log2 read counts)**: 5.4 {{:chemogenomics:nalm6 dist.png?nolink |}}